Response rates and kinetics on ibrutinib in WM patients according to CXCR4S338Xmutational status and clonality
| . | CXCR4S338X clonality . | CXCR4WT, n = 110 . | P . | |
|---|---|---|---|---|
| High, n = 23 . | Low, n = 14 . | |||
| Overall response, n (%) | 22 (96) | 12 (86) | 106 (96) | .19 | 
| Major response, n (%) | 15 (65) | 8 (57) | 94 (85) | .004 | 
| Very good partial response, n (%) | 1 (4) | 3 (21) | 38 (35) | .01 | 
| Time to minor response, mo | 2.1 | 1.8 | 1.1 | .0001 | 
| Time to major response, mo | 9.7 | 7.4 | 1.9 | .0003 | 
| . | CXCR4S338X clonality . | CXCR4WT, n = 110 . | P . | |
|---|---|---|---|---|
| High, n = 23 . | Low, n = 14 . | |||
| Overall response, n (%) | 22 (96) | 12 (86) | 106 (96) | .19 | 
| Major response, n (%) | 15 (65) | 8 (57) | 94 (85) | .004 | 
| Very good partial response, n (%) | 1 (4) | 3 (21) | 38 (35) | .01 | 
| Time to minor response, mo | 2.1 | 1.8 | 1.1 | .0001 | 
| Time to major response, mo | 9.7 | 7.4 | 1.9 | .0003 |